Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 3Waldenstrom Macroglobulinemia 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Colorectal Neoplasms 1Chemotherapy-induced Thrombocytopenia 1CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

romiplostim 1oprelvekin 1hetrombopag 1eltrombopag 1avatrombopag 1Interleukin-11 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-induced Thrombocytopenia × oprelvekin × Clear all
NCT05688306 2023-01-18

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Liaoning Cancer Hospital & Institute

Completed
3,494 enrolled
Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡